Qsymia is a prescription weight loss medication that is designed to help people reduce their appetite and lose weight. It is FDA-approved for use in adults with obesity and is considered safe for long ...
Two new prescription weight loss drugs, Belviq and Qsymia, now have the FDA's blessing. Which, if either, is for you? Both drugs help some people lose weight. Neither drug is for everyone. Yet the two ...
Qsymia (phentermine/topiramate) is a brand-name extended-release oral capsule prescribed for weight loss. The cost of the drug with and without insurance can depend ...
The US Food and Drug Administration (FDA) has approved a supplemental indication for the combination phentermine and topiramate extended-release capsules (Qsymia, Vivus LLC) in patients aged 12 years ...
-Conference in Seoul provides opportunity to introduce an international audience to the clinical safety and benefits of Qsymia following its approval in the Republic of Korea- CAMPBELL, Calif., Aug.
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced today that QSYMIA® (phentermine and topiramate extended-release capsules ...
Treatment with Qsymia was associated with reductions in systolic blood pressure compared with placebo or phentermine. Positive topline data were announced from a phase 4 study evaluating the effect of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results